User profiles for Janis Miyasaki

Janis Miyasaki

University of Alberta
Verified email at ualberta.ca
Cited by 25988

Effect of GPi pallidotomy on motor function in Parkinson's disease

AM Lozano, AE Lang, N Galvez-Jimenez, J Miyasaki… - The Lancet, 1995 - thelancet.com
The major motor disturbances in Parkinson's disease are thought to be caused by overactivity
of the internal segment of the globus pallidus (GPi), in large part due to excessive drive …

Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.

…, L Barclay, J Hubble, P LeWitt, J Miyasaki… - Archives of …, 2004 - europepmc.org
Objective To compare initial treatment with pramipexole vs levodopa in early Parkinson
disease, followed by levodopa supplementation, with respect to the development of …

A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease

…, RMA De Bie, P Wadia, J Miyasaki… - Movement …, 2008 - Wiley Online Library
Dementia is an important and increasingly recognized problem in Parkinson's disease (PD).
The mini‐mental state examination (MMSE) often fails to detect early cognitive decline. The …

Validation of the questionnaire for impulsive‐compulsive disorders in Parkinson's disease

…, CH Adler, MN Potenza, J Miyasaki… - … : official journal of the …, 2009 - Wiley Online Library
As no comprehensive assessment instrument for impulse control disorders (ICDs) in Parkinson's
disease (PD) exists, the aim of this study was to design and assess the psychometric …

Factors associated with dopaminergic drug–related pathological gambling in Parkinson disease

V Voon, T Thomsen, JM Miyasaki… - Archives of …, 2007 - jamanetwork.com
… Critical revision of the manuscript for important intellectual content: Voon, Thomsen, Miyasaki,
de Souza, Fox, Duff-Canning, Lang, and Zurowski. Statistical analysis: Shafro and Fox. …

Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice

…, V Dobričić, A Carracedo, I Petrović, JM Miyasaki… - Nature …, 2013 - nature.com
Calcifications in the basal ganglia are a common incidental finding and are sometimes inherited
as an autosomal dominant trait (idiopathic basal ganglia calcification (IBGC)). Recently, …

A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit

…, J Jimenez-Shahed, A Palao, JM Miyasaki… - JAMA …, 2014 - jamanetwork.com
Importance Coenzyme Q10 (CoQ10), an antioxidant that supports mitochondrial function, has
been shown in preclinical Parkinson disease (PD) models to reduce the loss of dopamine …

Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis [RETIRED] Report of the Therapeutics and Technology …

JJ Marriott, JM Miyasaki, G Gronseth, PW O'Connor - Neurology, 2010 - AAN Enterprises
Objective: The chemotherapeutic agent mitoxantrone was approved for use in multiple
sclerosis (MS) in 2000. After a review of all the available evidence, the original report of the …

Burnout, career satisfaction, and well-being among US neurologists in 2016

…, JR Molano, TR Vidic, JS Kass, JM Miyasaki… - Neurology, 2017 - AAN Enterprises
Janis M. Miyasaki: drafting and revising the manuscript for intellectual content. Jeff A. Sloan:
Miyasaki receives grants through PCORI and Parkinson Alberta and is a member of the …

Assessment: Efficacy of transcutaneous electric nerve stimulation in the treatment of pain in neurologic disorders (an evidence-based review) Report of the …

RM Dubinsky, J Miyasaki - Neurology, 2010 - AAN Enterprises
Objective: To determine if transcutaneous electric nerve stimulation (TENS) is efficacious in
the treatment of pain in neurologic disorders. Methods: We performed a systematic literature …